Robert R. Goodwin
Corporate Officer/Principal chez Takeda Vaccines (Montana), Inc.
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Donald P. Beeman | M | - |
LigoCyte Pharmaceuticals, Inc.
Takeda Vaccines (Montana), Inc.
Takeda Vaccines (Montana), Inc. Pharmaceuticals: MajorHealth Technology Takeda Vaccines (Montana), Inc. operates as a biopharmaceutical company which focuses on the development of vaccines that prevent human infectious diseases. It specializes in developing vaccines against norovirus, influenza, and respiratory syncytial virus. The firm develops norovirus VLP vaccines that mimic the surface configuration of the live virus without the ability to cause infection, respiratory syncytial virus vaccine that mediates cell entry in its native form for use in anthrax treatment. The company was founded by Robert F. Bargatze on March 13, 2008 and is headquartered in Bozeman, MT. | - |
Robert F. Bargatze | M | - |
LigoCyte Pharmaceuticals, Inc.
Takeda Vaccines (Montana), Inc.
Takeda Vaccines (Montana), Inc. Pharmaceuticals: MajorHealth Technology Takeda Vaccines (Montana), Inc. operates as a biopharmaceutical company which focuses on the development of vaccines that prevent human infectious diseases. It specializes in developing vaccines against norovirus, influenza, and respiratory syncytial virus. The firm develops norovirus VLP vaccines that mimic the surface configuration of the live virus without the ability to cause infection, respiratory syncytial virus vaccine that mediates cell entry in its native form for use in anthrax treatment. The company was founded by Robert F. Bargatze on March 13, 2008 and is headquartered in Bozeman, MT. | 26 ans |
Larry W. Mikkola | M | - |
LigoCyte Pharmaceuticals, Inc.
Takeda Vaccines (Montana), Inc.
Takeda Vaccines (Montana), Inc. Pharmaceuticals: MajorHealth Technology Takeda Vaccines (Montana), Inc. operates as a biopharmaceutical company which focuses on the development of vaccines that prevent human infectious diseases. It specializes in developing vaccines against norovirus, influenza, and respiratory syncytial virus. The firm develops norovirus VLP vaccines that mimic the surface configuration of the live virus without the ability to cause infection, respiratory syncytial virus vaccine that mediates cell entry in its native form for use in anthrax treatment. The company was founded by Robert F. Bargatze on March 13, 2008 and is headquartered in Bozeman, MT. | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Ivor Royston | M | 79 |
LigoCyte Pharmaceuticals, Inc.
| 4 ans |
Benjamin Auspitz | M | 51 |
LigoCyte Pharmaceuticals, Inc.
| - |
Markus Goebel | M | - |
LigoCyte Pharmaceuticals, Inc.
| - |
Paul M. Mendelman | M | 76 |
LigoCyte Pharmaceuticals, Inc.
| - |
Charles Richardson | M | 72 |
LigoCyte Pharmaceuticals, Inc.
| 12 ans |
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 8 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Robert R. Goodwin
- Réseau Personnel